Prices are updated after-hours

United states

Bellicum Pharmaceuticals, Inc.

BLCM | $0.0748 381.28% 6.1K

(0.0% 1d) (0.0% 1m) (-82.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3229.12% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 726,826
http://www.bellicum.com
Sec Filling | Patents | 107 employees

(US) Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.

cancer immunotherapy

add to watch list Paper trade email alert is off

Benefitfocus, Inc.

BNFT 4 | $10.5 0.1% 0

Technology Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (47.19% volume)
Earnings Calendar: 2023-02-28
Market Cap: $ 362,024,618
http://www.benefitfocus.com
Sec Filling | Patents | 1560 employees

(US) Benefitfocus, Inc. engages in the provision of cloud-based benefits management platform for consumers, employers, insurance carriers, and brokers. The company was founded by Mason R. Holland and Shawn A. Jenkins in June 2000 and is headquartered in Charleston, SC.

insurance

add to watch list Paper trade email alert is off

BGC Partners, Inc.

BGCP | $4.43 1.24% 3.5M

Finance

(0.0% 1d) (0.0% 1m) (-7.7% 1y) (0.0% 2d) (2.8% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-08-02
Market Cap: $ 1,499,497,849
http://www.bgcpartners.com
Sec Filling | Patents | 5200 employees

(US) BGC Partners, Inc. engages in the provision of brokerage services to the financial markets. The firm offers integrated voice, hybrid, and fully electronic brokerage in a broad range of products, including fixed income, foreign exchange, equities, insurance, energy and commodities, and futures. It also provides trade execution, brokerage, clearing, trade compression, post-trade, information, and other back-office services. The company was founded in 1945 and is headquartered in New York, NY.

energy insurance electronics

add to watch list Paper trade email alert is off

Biocept, Inc.

BIOC | $0.4349 -10.32% 750K

Health Services

(0.0% 1d) (0.0% 1m) (22.1% 1y) (0.0% 2d) (0.0% 3d) (-13.1% 7d) (-9.6% volume)
Earnings Calendar: 2023-04-17
Market Cap: $ 1,142,059
http://www.biocept.com
Sec Filling | Patents | 88 employees

(US) Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

tumor cells t-cell clinical trials ceiling

add to watch list Paper trade email alert is off

Brickell Biotech, Inc.

BBI | $2.12 16.04%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-74.2% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 6,092,806
http://www.brickellbio.com
Sec Filling | Patents | 15 employees

(US) Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.

dermatitis skin t-cell treatment ceiling

add to watch list Paper trade email alert is off

Cardiovascular Systems, Inc.

CSII | $20.0 -0.05% 400K

Health Technology

(0.0% 1d) (0.0% 1m) (0.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (22.61% volume)
Earnings Calendar: 2023-05-04
Market Cap: $ 843,960,960
http://www.csi360.com
Sec Filling | Patents | 779 employees

(US) Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The firm's products are catheter-based platforms capable of treating a range of vessel sizes and plaque types. The company was founded in 1989 and is headquartered in St. Paul, MN.

cardiovascular

add to watch list Paper trade email alert is off

Casa Systems, Inc.

CASA | $0.055 -40.91% 65M

Electronic Technology

(0.0% 1d) (-81.1% 1m) (-95.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (17290.59% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 5,450,995
http://www.casa-systems.com
Sec Filling | Patents | 997 employees

(US) Casa Systems, Inc. engages in the provision and development of digital cable video and broadband services. Its products include cable, fixed, mobile, optical, and Wi-Fi networks; and casa access devices. The company was founded by Jerry Guo in 2003 and is headquartered in Andover, MA.

optical c-abl

add to watch list Paper trade email alert is off

CDK Global, Inc.

CDK | $54.76 -0.15% 0.07%

Commercial Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1485.09% volume)
Earnings Calendar: 2022-08-17
Market Cap: $ 6,390,481,158
http://www.cdkglobal.com
Sec Filling | Patents | 9000 employees

(US) CDK Global, Inc. engages in the provision of integrated information technology and digital marketing solutions to the automotive retail industry. It operates through following segments: CDK North America and CDK International. The CDK North America segment provides technology-based solutions. The CDK International segment caters to the United States and Canada. The company was founded on September 30, 2014 and is headquartered in Hoffman Estates, IL.

automotive information technology digital marketing 3d

add to watch list Paper trade email alert is off

Change Healthcare Inc.

CHNG | $27.49 -2.98%

Technology Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-0.1% 3d) (0.0% 7d) (164.47% volume)
Earnings Calendar: 2022-11-02
Market Cap: $ 9,025,201,215
http://www.changehealthcare.com
Sec Filling | Patents | 15000 employees

(US) Change Healthcare, Inc. operates as a healthcare technology company. It offers software, analytics, network solutions, and technology-enabled services. The firm's products include ANSOS staff scheduling, HealthQx, hospital revenue cycle services, coding advisor, revenue performance advisor, and InterQual. The company was founded in 2007 and is headquartered in Alpharetta, GA.

msa

add to watch list Paper trade email alert is off

ChemoCentryx, Inc.

CCXI | $51.99 -0.04%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (160.14% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 3,709,791,785
http://www.chemocentryx.com
Sec Filling | Patents | 82 employees

(US) ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

cancer autoimmunity

add to watch list Paper trade email alert is off

Chinook Therapeutics, Inc.

KDNY | $40.39 0.22% -0.17% 0

Health Technology

(0.0% 1d) (0.0% 1m) (80.2% 1y) (0.0% 2d) (0.2% 3d) (0.0% 7d) (-30.62% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 2,900,203,021
http://www.chinooktx.com
Sec Filling | Patents | 96 employees

(US) Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.

kidney diseases kidney

add to watch list Paper trade email alert is off

AgroFresh Solutions, Inc.

AGFS | $3.0 -0.27% 0

Process Industries

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-66.09% volume)
Earnings Calendar: 2023-05-10
Market Cap: $ 161,152,722
http://www.agrofresh.com
Sec Filling | Patents | 292 employees

(US) AgroFresh Solutions, Inc. engages in the provision of food preservation and waste reduction solutions for fresh produce. It offers products through the following brands: Smarter Freshness, Harvista, LandSpring, SmartFresh, AdvanStore, and ActiMist, Textar, and Teycer. The company was founded on October 24, 2013 and is headquartered in Philadelphia, PA.

food brands

add to watch list Paper trade email alert is off

Albireo Pharma, Inc.

ALBO | $44.15 -0.23% 0.39% 1.2M

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-02-28
Market Cap: $ 913,961,644
http://www.albireopharma.com
Sec Filling | Patents | 55 employees

(US) Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

gastrointestinal liver liver disease treatment odevixibat

add to watch list Paper trade email alert is off

American National Group, Inc.

ANAT | $190.02 0.18% -0.22%

Finance

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.2% 7d) (169.57% volume)
Earnings Calendar:
Market Cap:
http://www.americannational.com
Sec Filling | Patents | 4600 employees

(US) American National Group, Inc. operates as an insurance company. It engages in the provision of life insurance, annuities, health insurance, credit insurance, pension products and property, and casualty insurance for personal lines, agribusiness, and commercial exposures. The company is headquartered in Galveston, TX.

insurance

add to watch list Paper trade email alert is off

Amyris, Inc.

AMRS | $0.05 -21.88% -16.36% 47M

Process Industries

(0.0% 1d) (0.0% 1m) (-92.6% 1y) (0.0% 2d) (-19.5% 3d) (0.0% 7d) (46.83% volume)
Earnings Calendar: 2023-08-08
Market Cap: $ 18,469,281
http://www.amyris.com
Sec Filling | Patents | 561 employees

(US) Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Drugs

Squalane plus Mineral SPF 45 (Titanium Dioxide and Zinc Oxide)

add to watch list Paper trade email alert is off

Antares Pharma, Inc.

ATRS | $5.59 0.0%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (53.54% volume)
Earnings Calendar: 2022-08-04
Market Cap:
http://www.antarespharma.com
Sec Filling | Patents | 178 employees

(US) Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.

injection ycombinator

Drugs

Otrexup (methotrexate)
XYOSTED (testosterone enanthate)

add to watch list Paper trade email alert is off

Apollo Medical Holdings, Inc.

AMEH | $40.82 -0.81% 310K

Health Services

(0.0% 1d) (0.0% 1m) (3.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (163.8% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,379,136,103
http://www.apollomed.net
Sec Filling | Patents | 555 employees

(US) Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

add to watch list Paper trade email alert is off

Applied Genetic Technologies Corporation

AGTC | $0.3936 1.23% 0.0%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-80.43% volume)
Earnings Calendar: 2022-11-08
Market Cap:
http://www.agtc.com
Sec Filling | Patents | 83 employees

(US) Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

gene therapies genetic clinical trials

add to watch list Paper trade email alert is off

Aravive, Inc.

ARAV | $0.0401 4.74% 4M

Health Technology

(0.0% 1d) (0.0% 1m) (-97.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-85.6% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 2,949,862
http://www.aravive.com
Sec Filling | Patents | 17 employees

(US) Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

cancer t-cell ovarian cancer treatment ceiling

add to watch list Paper trade email alert is off

Athenex, Inc.

ATNX | $0.2031 -7.78% 1.9M

Health Technology

(0.0% 1d) (0.0% 1m) (-86.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (199.02% volume)
Earnings Calendar: 2022-10-27
Market Cap: $ 1,759,498
http://www.athenex.com
Sec Filling | Patents | 574 employees

(US) Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Global Supply Chain Platform segment provides supply of active pharmaceutical ingredients (APIs) for clinical and commercial efforts. The Commercial Platform segment involves in the sales and marketing of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.

cancer tirbanibulin treatment

add to watch list Paper trade email alert is off